Speed Medical results, Q2 2021
Net profit, assets, equity and cash flow for Q2 2021, against the same period a year earlier, from the published financial statements.
Net profit33.32 millionEGP
Total assets619 millionEGP
Shareholders' equity459 millionEGP
Operating cash flow755 thousandEGP
In short
- Speed Medical's net profit for Q2 2021 was about 33.32 million EGP.
- Total assets at the end of Q2 2021 were about 619 million EGP, and shareholders' equity about 459 million EGP.
- Operating cash flow for Q2 2021 was positive at 755 thousand EGP.
Key lines against the same period a year earlier
This periodYear earlierChange
Net profit33.32 million——
Gross profit60.33 million——
Total assets619 million——
Total liabilities160 million——
Shareholders' equity459 million——
Total liabilities and equity619 million——
Operating cash flow755 thousand——
Investing cash flow-1.16 million——
Financing cash flow10.07 million——
Net change in cash9.66 million——
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Speed Medical's Q2 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy